{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:23:48Z","timestamp":1759742628041,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["14442"],"award-info":[{"award-number":["14442"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s11033-021-06821-z","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T14:28:36Z","timestamp":1634308116000},"page":"7913-7920","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlations between vitronectin, miR-520, and miR-34 in patients with stenosis of coronary arteries"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9309-5381","authenticated-orcid":false,"given":"Ghasem","family":"Ghasempour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3992-0088","authenticated-orcid":false,"given":"Farhad","family":"Shaikhnia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1430-8431","authenticated-orcid":false,"given":"Ali Akbar","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2167-3314","authenticated-orcid":false,"given":"Borhan","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0622-4174","authenticated-orcid":false,"given":"Mohammad","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"issue":"3","key":"6821_CR1","first-page":"e13200","volume":"44","author":"MJ Kim","year":"2020","unstructured":"Kim MJ, Jung SK (2020) Nutraceuticals for prevention of atherosclerosis: targeting monocyte infiltration to the vascular endothelium. J Food Biochem 44(3):e13200","journal-title":"J Food Biochem"},{"issue":"10","key":"6821_CR2","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.3390\/ijms18102034","volume":"18","author":"M-Y Wu","year":"2017","unstructured":"Wu M-Y et al (2017) New insights into the role of inflammation in the pathogenesis of atherosclerosis. Int J Mol Sci 18(10):2034","journal-title":"Int J Mol Sci"},{"issue":"12","key":"6821_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1042\/CS20180306","volume":"132","author":"GR Geovanini","year":"2018","unstructured":"Geovanini GR, Libby P (2018) Atherosclerosis and inflammation: overview and updates. Clin Sci 132(12):1243\u20131252","journal-title":"Clin Sci"},{"issue":"4","key":"6821_CR4","doi-asserted-by":"publisher","first-page":"506","DOI":"10.21037\/acs.2018.05.17","volume":"7","author":"C Spadaccio","year":"2018","unstructured":"Spadaccio C, Benedetto U (2018) Coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in the treatment of multivessel coronary disease: quo vadis?\u2014a review of the evidences on coronary artery disease. Annals of cardiothoracic surgery 7(4):506","journal-title":"Annals of cardiothoracic surgery"},{"key":"6821_CR5","volume-title":"Percutaneous transluminal coronary angioplasty (PTCA)","author":"TF Malik","year":"2019","unstructured":"Malik TF, Tivakaran VS (2019) Percutaneous transluminal coronary angioplasty (PTCA). StatPearls, Treasure Island"},{"issue":"1","key":"6821_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nrcardio.2011.132","volume":"9","author":"JW Jukema","year":"2012","unstructured":"Jukema JW et al (2012) Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol 9(1):53","journal-title":"Nat Rev Cardiol"},{"key":"6821_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/B978-0-12-810420-0.00033-X","volume-title":"The complement facts book","author":"Y-C Su","year":"2018","unstructured":"Su Y-C, Riesbeck K (2018) Vitronectin. The complement facts book. Elsevier, Amsterdam, pp 351\u2013360"},{"issue":"8","key":"6821_CR8","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1111\/j.1538-7836.2010.03907.x","volume":"8","author":"N Garg","year":"2010","unstructured":"Garg N et al (2010) Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices. J Thromb Haemost 8(8):1847\u20131854","journal-title":"J Thromb Haemost"},{"issue":"12","key":"6821_CR9","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1111\/jth.13869","volume":"15","author":"M Luo","year":"2017","unstructured":"Luo M et al (2017) Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin. J Thromb Haemost 15(12):2451\u20132460","journal-title":"J Thromb Haemost"},{"issue":"4","key":"6821_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s13346-017-0404-5","volume":"8","author":"E Grad","year":"2018","unstructured":"Grad E et al (2018) The role of monocyte subpopulations in vascular injury following partial and transient depletion. Drug Deliv Trans Res 8(4):945\u2013953","journal-title":"Drug Deliv Trans Res"},{"issue":"2","key":"6821_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7150\/thno.7210","volume":"4","author":"R-X Yin","year":"2014","unstructured":"Yin R-X, Yang D-Z, Wu J-Z (2014) Nanoparticle drug-and gene-eluting stents for the prevention and treatment of coronary restenosis. Theranostics 4(2):175","journal-title":"Theranostics"},{"issue":"4","key":"6821_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1055\/s-0037-1601871","volume":"26","author":"S Shafiee","year":"2017","unstructured":"Shafiee S et al (2017) Vitronectin and urokinase-type plasminogen activator gene expression levels are increased in patients with coronary artery in-stent restenosis. Int J Angiol 26(4):218","journal-title":"Int J Angiol"},{"key":"6821_CR13","doi-asserted-by":"publisher","first-page":"145131","DOI":"10.1016\/j.gene.2020.145131","volume":"765","author":"N Kakavandi","year":"2021","unstructured":"Kakavandi N et al (2021) Prostaglandin E2 (PGE2) synthesis pathway is involved in coronary artery stenosis and restenosis. Gene 765:145131","journal-title":"Gene"},{"issue":"9","key":"6821_CR14","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.2174\/1871530320666200511012142","volume":"20","author":"S Rezaee","year":"2020","unstructured":"Rezaee S et al (2020) COX and PTGDS gene expression levels in PGD2 synthesis pathway are correlated with miR-520 in patients with vessel restenosis. Endocr, Metab Immune Disord-Drug Targets 20(9):1514\u20131522","journal-title":"Endocr, Metab Immune Disord-Drug Targets"},{"key":"6821_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.coph.2021.07.022","volume":"60","author":"A Collado","year":"2021","unstructured":"Collado A et al (2021) MicroRNA: a mediator of diet-induced cardiovascular protection. Curr Opin Pharmacol 60:183\u2013192","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"6821_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13105-020-00779-5","volume":"77","author":"Y Jiao","year":"2021","unstructured":"Jiao Y et al (2021) MicroRNA-520c-3p suppresses vascular endothelium dysfunction by targeting RELA and regulating the AKT and NF-\u03baB signaling pathways. Journal Physiol Biochem 77(1):47\u201361","journal-title":"Journal Physiol Biochem"},{"issue":"4","key":"6821_CR17","doi-asserted-by":"crossref","first-page":"204589402097491","DOI":"10.1177\/2045894020974919","volume":"10","author":"Z Wu","year":"2020","unstructured":"Wu Z et al (2020) MiR-193-3p attenuates the vascular remodeling in pulmonary arterial hypertension by targeting PAK4. Pulm Circ 10(4):2045894020974919","journal-title":"Pulm Circ"},{"issue":"8","key":"6821_CR18","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3390\/biomedicines9081055","volume":"9","author":"R Badacz","year":"2021","unstructured":"Badacz R et al (2021) Expression of miR-1-3p, miR-16-5p and miR-122-5p as possible risk factors of secondary cardiovascular events. Biomedicines 9(8):1055","journal-title":"Biomedicines"},{"issue":"1","key":"6821_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jacc.2003.08.026","volume":"43","author":"D Fukuda","year":"2004","unstructured":"Fukuda D et al (2004) Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 43(1):18\u201323","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"6821_CR20","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/0735-1097(92)90365-T","volume":"20","author":"RF Fishman","year":"1992","unstructured":"Fishman RF et al (1992) Long-term results of directional coronary atherectomy: predictors of restenosis. J Am Coll Cardiol 20(5):1101\u20131110","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"6821_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/174182679500200108","volume":"2","author":"A G\u00fcrlek","year":"1995","unstructured":"G\u00fcrlek A et al (1995) Restenosis after transluminal coronary angioplasty: a risk factor analysis. Eur J Cardiovasc Prev Rehabil 2(1):51\u201355","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"5","key":"6821_CR22","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1161\/01.CIR.90.5.2267","volume":"90","author":"AG Violaris","year":"1994","unstructured":"Violaris AG, Melkert R, Serruys PW (1994) Influence of serum cholesterol and cholesterol subfractions on restenosis after successful coronary angioplasty. A quantitative angiographic analysis of 3336 lesions. Circulation 90(5):2267\u20132279","journal-title":"Circulation"},{"issue":"3","key":"6821_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.15171\/jcvtr.2015.24","volume":"7","author":"A Yaghoubi","year":"2015","unstructured":"Yaghoubi A et al (2015) Correlation of serum levels of vitronectin, malondialdehyde and Hs-CRP with disease severity in coronary artery disease. J Cardiovasc Thorac Res 7(3):113","journal-title":"J Cardiovasc Thorac Res"},{"issue":"3","key":"6821_CR24","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1023\/A:1025000810466","volume":"14","author":"H Ekmekci","year":"2002","unstructured":"Ekmekci H et al (2002) Plasma vitronectin levels in patients with coronary atherosclerosis are increased and correlate with extent of disease. J Thromb Thrombolysis 14(3):221\u2013225","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"6821_CR25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/pro.3770","volume":"29","author":"Y Chu","year":"2020","unstructured":"Chu Y, Bucci JC, Peterson CB (2020) Identification of a PAI-1\u2010binding site within an intrinsically disordered region of vitronectin. Protein Sci 29(2):494\u2013508","journal-title":"Protein Sci"},{"issue":"2","key":"6821_CR26","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/jcp.22993","volume":"227","author":"P Liu","year":"2012","unstructured":"Liu P, Wilson MJ (2012) miR-520c and miR-373 target mTOR and SIRT1, activate the Ras\/Raf\/MEK\/Erk pathway and NF-\u03baB, with up-regulation of MMP9 in human fibrosarcoma cells. J Cell Physiol 227(2):867","journal-title":"J Cell Physiol"},{"issue":"5","key":"6821_CR27","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.3892\/ol.2016.5085","volume":"12","author":"M Yi","year":"2016","unstructured":"Yi M et al (2016) miR-520e regulates cell proliferation, apoptosis and migration in breast cancer. Oncol Lett 12(5):3543\u20133548","journal-title":"Oncol Lett"},{"issue":"6","key":"6821_CR28","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.cellsig.2014.12.022","volume":"27","author":"N Choe","year":"2015","unstructured":"Choe N et al (2015) The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor. Cell Signal 27(6):1056\u20131065","journal-title":"Cell Signal"},{"issue":"2","key":"6821_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/cdd.2009.56","volume":"17","author":"H Hermeking","year":"2010","unstructured":"Hermeking H (2010) The miR-34 family in cancer and apoptosis. Cell Death Differ 17(2):193\u2013199","journal-title":"Cell Death Differ"},{"issue":"3","key":"6821_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/biof.1704","volume":"47","author":"JM Lin","year":"2021","unstructured":"Lin JM et al (2021. May) BCL-6 promotes the methylation of miR\u201034a by recruiting EZH2 and upregulating CTRP9 to protect ischemic myocardial injury. BioFactors 47(3):386\u2013402","journal-title":"BioFactors"},{"issue":"2","key":"6821_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.5603\/KP.a2017.0243","volume":"76","author":"J Gaco\u0144","year":"2018","unstructured":"Gaco\u0144 J et al (2018) Diagnostic and prognostic micro-RNAs in ischaemic stroke due to carotid artery stenosis and in acute coronary syndrome: a four-year prospective study. Kardiol Polska 76(2):362\u2013369","journal-title":"Kardiol Polska"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06821-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06821-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T19:17:46Z","timestamp":1637349466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06821-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6821"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06821-z","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"26 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"It was approved by the Committee on the Ethics of IUMS (IR.IUMS.FMD.REC.1397.341).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}},{"value":"All procedures performed in studies involving human participants were following the ethical standards of the institutional research committee with the 1964 Helsinki declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}